NANOBIOTIX (EPA:NANO) | WebDisclosure

Basculer en Français

11218	Companies
248758	Keywords
176532	Articles
134595	Press releases

Home
Companies
NANOBIOTIX

PRESS RELEASE

published on 05/28/2024 at 22:15, 2 years 4 months ago

NANOBIOTIX annonce une présentation de nouvelles données et du programme d’immunothérapie de Phase 1 lors de la réunion annuelle 2024 de l’American Society for Clinical Oncology (ASCO) suivi d’une conférence téléphonique et webcast
Nanobiotix annonce la présentation de nouvelles données et du programme d'immunothérapie de phase 1 lors de la réunion annuelle 2024 de l'ASCO, suivi d'une conférence téléphonique et webcast

Immunothérapie Cancer ASCO 2024 NANOBIOTIX NBTXR3
PRESS RELEASE

published on 05/28/2024 at 22:15, 2 years 4 months ago

NANOBIOTIX Announces Presentation of new Data From Phase 1 Immunotherapy Program at the 2024 Annual Meeting of the American Society for Clinical Oncology Followed by an Investor Conference Call
Nanobiotix to present new data from Phase 1 immunotherapy program at 2024 ASCO meeting followed by investor conference call. Details for the call provided

Investor Conference Call Immunotherapy ASCO 2024 NANOBIOTIX Phase 1
BRIEF

published on 05/23/2024 at 22:20, 2 years 4 months ago

NANOBIOTIX to Present at the Jefferies Global Healthcare Conference

Biotechnology Cancer Treatment Webcast NANOBIOTIX Jefferies Global Healthcare Conference
BRIEF

published on 05/23/2024 at 22:20, 2 years 4 months ago

NANOBIOTIX fera une présentation à la conférence Jefferies Global Healthcare

Biotechnologie Webdiffusion Traitement Du Cancer NANOBIOTIX Conférence Mondiale Jefferies Sur Les Soins De Santé
PRESS RELEASE

published on 05/23/2024 at 22:15, 2 years 4 months ago

NANOBIOTIX to Present at the Jefferies Global Healthcare Conference
Nanobiotix to present at the Jefferies Global Healthcare Conference on June 5, 2024, with Bart Van Rhijn, CFO, participating in a fireside chat. Company pioneering physics-based approaches for cancer treatment

Cancer Treatment Biotechnology Company NANOBIOTIX Jefferies Global Healthcare Conference Physics-based Approaches
PRESS RELEASE

published on 05/23/2024 at 22:15, 2 years 4 months ago

NANOBIOTIX participera à la conférence Jefferies Global Healthcare
Nanobiotix participera à la conférence Jefferies Global Healthcare pour discuter de ses avancées en biotechnologie. Détails de l'événement et webcast disponibles

Biotechnologie Traitement Cancer NANOBIOTIX Conférence Jefferies
BRIEF

published on 05/21/2024 at 22:20, 2 years 5 months ago

Nanobiotix Announces Advancement in NBTXR3 Development and Strategic Collaboration

Biotechnology Cancer Therapy NANOBIOTIX NBTXR3 Janssen Collaboration
BRIEF

published on 05/21/2024 at 22:20, 2 years 5 months ago

Nanobiotix annonce des progrès dans le développement de NBTXR3 et une collaboration stratégique

Biotechnologie Thérapie Contre Le Cancer NANOBIOTIX NBTXR3 Collaboration Janssen
PRESS RELEASE

published on 05/21/2024 at 22:15, 2 years 5 months ago

Nanobiotix Announces Progress in Global NBTXR3 Development Collaboration Highlighting Robust Pipeline and Pathway to Long-Term Growth
Nanobiotix announces progress in global NBTXR3 development collaboration, highlighting robust pipeline and pathway to long-term growth in cancer treatment. Updates include US FDA approvals and strategic study modifications

Cancer Treatment NANOBIOTIX NBTXR3 Global Development FDA Approvals
PRESS RELEASE

published on 05/21/2024 at 22:15, 2 years 5 months ago

Nanobiotix annonce des avancees de la collaboration globale de developpement autour de NBTXR3 refletant son pipeline robuste et son approche de croissance sur le long terme
Nanobiotix annonce des avancées de la collaboration globale de développement autour de NBTXR3 reflétant son pipeline robuste et son approche de croissance sur le long terme

Croissance À Long Terme NANOBIOTIX NBTXR3 Collaboration Globale Pipeline Robuste

Accesswire

Published on 10/23/2026 at 02:20, 2 hours 19 minutes ago

Apex Announces Nasdaq Listing and Pricing of US$1.86 Million Offering
Published on 10/22/2026 at 23:30, 5 hours 9 minutes ago

Cypher Announces Subscription Receipt Offering
Published on 10/22/2026 at 22:30, 6 hours 9 minutes ago

Unusual Machines to Announce Third Quarter 2026 Financial Results and Provide Corporate Update
Published on 10/22/2026 at 16:00, 12 hours 39 minutes ago

Future Fuels Announces Closing of Brokered Offering for Gross Proceeds of C$6.6 Million
Published on 10/22/2026 at 14:30, 14 hours 9 minutes ago

Unusual Machines Receives $16.9 Million Purchase Order from Powerus for American-Made Drone Components

View all ACCESSWIRE

EQS Group

Published on 10/23/2026 at 01:55, 2 hours 44 minutes ago

Guardian. For Family｜TIGGO7 Crash Test Results Demonstrate CHERY's Commitment to Family Safety
Published on 10/22/2026 at 22:10, 6 hours 29 minutes ago

Quantinuum to Report Third Quarter Financial Results on November 5, 2026
Published on 10/22/2026 at 20:00, 8 hours 39 minutes ago

Exchange offer for Eleving Group 2023/2028 bonds (ISIN DE000A3LL7M4) completed
Published on 10/22/2026 at 19:45, 8 hours 54 minutes ago

EUROPLASMA: Les Forges de Tarbes sollicitent l’ouverture d’une procédure de redressement judiciaire
Published on 10/22/2026 at 18:45, 9 hours 54 minutes ago

Swedish Export Credit Corporation (SEK): Europe's defence build-up opens opportunities for Swedish companies in Germany

Les Echos

Published on 10/22/2026 at 18:00, 10 hours 39 minutes ago

THERMADOR GROUPE : Completion of the share buy-back programme launched in August
Published on 10/22/2026 at 18:00, 10 hours 39 minutes ago

THERMADOR GROUPE : Fin du programme de rachat d’actions débuté en août
Published on 10/22/2026 at 18:00, 10 hours 39 minutes ago

bioMérieux receives Dual 510(k) Clearance and CLIA Waiver from the FDA for the BIOFIRE® SPOTFIRE® Vaginitis Panel to Advance Women’s Health with Rapid Molecular Diagnostics
Published on 10/22/2026 at 18:00, 10 hours 39 minutes ago

bioMérieux obtient l’autorisation 510(k) et la dérogation CLIA de la FDA pour son test BIOFIRE® SPOTFIRE® Vaginitis Panel : une avancée pour améliorer la santé des femmes grâce au diagnostic moléculaire rapide
Published on 10/22/2026 at 18:00, 10 hours 39 minutes ago

1er semestre 2026 : résultats opérationnels en nette amélioration

View all LES ECHOS COMFI WIRE